Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 21, 2024Open Access

Overcoming Hemophilia A Gene Therapy Limitations with an Enhanced Function Factor VIII Variant

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAnna R. SternbergChildren's Hospital of PhiladelphiaCMCristina Martos-RusChildren's Hospital of PhiladelphiaRDRobert J. DavidsonChildren's Hospital of Philadelphia

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sternberg et al. (2024) studied this question.

synapsesocial.com/papers/68e69229b6db643587618d8bhttps://doi.org/10.1101/2024.05.16.594568
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The influence of factor VIII on measurement of activated protein C resistance1996 · 69 citations
  2. 2Regulation of Factor VIIIa in the Intrinsic Factor Xase1999 · 47 citations
  3. 3Effect of Genome Size on AAV Vector Packaging2009 · 1,020 citations
  4. 4High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism2000 · 768 citations
  5. 5Adeno-Associated Virus Gene Therapy for Hemophilia2022 · 133 citations